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l~e v n ord~ Tetrahydro-9-ammoacrldlne,  N-Methyl-D-aspartlc acid D~ssocmtwe anesthetic, ]~-(l-[2- 
Thlenyl]cyclohexyl)-3A-plpendme, Phencychdme Alzhelmers  &sease Glutamate  Htppo- 
campus  
The effect ot te t rahydro-9-ammoacndme (THA) and related compounds  on hgand binding to the &sso- 
clatwe anesthetic (phencychdme, PCP) receptor site was assessed using a rat brain homogenate  assa'y 
THA displaced the &ssoclatwe anesthetic hgand [~H]N-(l-[2-thlenyl]cyclohexyl)3-4-plpendme ([~H]TC~P) 
binding with an ICs0 of  26 u M  Other acridine derlvatzves &splayed similar potency as &splacers ol 
[~H]TCP Chohnesterase mhlbltors and ammopyr tdmes  had ICs0s equal to or greater than 100/tM Satu- 
ration studies of  [~HITCP m the presence and absence of  30 pM T H A  revealed competitive mhlbltlon with 
a K~ ot 15/tM The chmcal pharmacology of  T H A  suggests that it antagomzes the effects o! dJssoclatl~e 
anesthet~t~s whereas m vitro, it behaves as a weak PCP agomst  THA may exert some of  Its chmcal effects 
through interaction with the PCP receptor and may have mixed agomst  antagomst  properties 
Tetrahydro-9-aminoacridine (THA) is an orally administered, centrally active cho- 
hnesterase inhibitor recently reported to ameliorate significantly the cognitive deficits 
of  dementia of  the Alzhelmer's type (DAT) [16] While the effects of  T H A  have been 
attributed to ~ts action as a chohnesterase mhlbltor, clinical trials of  other chohnes- 
terase lnhlbitors have yielded unimpressive results [6] This discrepancy suggests that 
THA may have additional modes of  action 
THA has a complicated pharmacology It has been found to reverse morphine arid 
magnesium chloride induced coma [13] and to attenuate the intensity of  narcotic 
withdrawal symptoms [3, 15] It is a potassium and sodium channel blocker [12, 14] 
It has also been found to decrease the duration of  anesthesia induced by the dissocia- 
tive anesthetics, phencychdlne (PCP) and ketamme [1, 2, 4], as well as to reduce the 
emergence symptoms associated with ketamine anesthesia in both man and animals 
[1.4] 
PCP receptor density decreases have been documented in DAT [10, 11] The PCP 
receptor is functionally associated with the N-methyl-D-aspartate (NMDA)  subtype 
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of  excitatory ammo aod  receptors and N M D A  receptor density also dechnes m DAq 
[8] N M D A  receptors are particularly promment m the hlppocampus where the brunt 
of DAT pathology falls 
Because THA apparently antagomzes some of  the effects of PCP-hke drugs, we 
stu&ed the possible interaction of  THA and structurally related compounds with the 
PCP receptor site We also studied the effects of  other chohnesterase mhlbltors and 
structurally related potassmm channel blockers 
Rat forebram membranes were homogemzed m 50 mM Tns-acetate buffer (pH 7 0 
at 4°C) with a Polytron at a setting of  7 Membranes were then centrifuged for 20 
mm at 20,000 g The pellet was resuspended m 50 mM Trls-acetate buffer, (pH 7 0 
at room temperature) Varying concentrations of  THA and related compounds were 
incubated with prepared membranes and the specific PCP hgand [3H]N-(1-[2-thlenyl]- 
cyclohexyl)-3,4-plperldme (TCP) at a concentration of  10 nM Trlphcate samples 
were incubated for 30 mm at room temperature, then filtered over GF/B glass filters 
Fdters were washed twice wRh 4 ml 50 mM Tns-acetate buffer (pH 7 0 at 4°C) All 
filters were pre-soaked in 0 5% polyethylenelmme to ehmlnate binding of [3H]TCP 
to the filters Filters were immersed m 5 ml aqueous counting solution (Amersham) 
and ra&oactwlty determined m a Beckman LS 8100 sclntdlatlon counter Non-speci- 
fic binding was assessed with the addmon of  10/tM TCP 
THA displaced [3H]TCP with an IC50 of  26/tM (Table I) The acridine denvatwes 
9-ammoacndlne and proflawn were of comparable potency (Table I) The chohnes- 
terase inhibitor neostlgmme had an IC50 greater than 100/IM Two other chohnester- 
ase mhlbltors, physostlgmme and edrophomum, had ICs0s of  100/tM Three amino 
TABLE I 
IC5o VALUES FOR THA AND 2 RELATED ACRIDINES, 3 CHOLINESTERASE INHIBITORS 
AND 3 AMINOPYRIDINES 
The latter are potent potassmm channel blockers THA and the related acridines inhibit [~H]TCP binding 
w~th ICs0s m the low mlcromolar range Chohnesterase mhlbltors and ammopyndmes are cons~derabl~ 
less potent (mean of 3 experiments) 







Neostlgmlne > 100 
Edrophonmm 100 
Ammopyndlnes 
4-Ammopyndme > 100 
3A-Dlammopyndme > 100 
3-Ammopyrldme > 100 
~05 
pyndlnes, potent potassium channel blockers structurally related to THA, had ICs0s 
greater than 100/~M 
To investigate the nature of the interaction of THA with the PCP receptor site we 
performed saturation curves for [3H]TCP in the presence and absence of  30 /LM 
THA For [~H]TCP binding In the absence of  THA, Scatchard analysis indicated a 
single class of binding sites with a mean Kd of 45 nM (S D = 7 64, n = 3) and mean 
Bma~ of 773 fmol/mg protein (S D = 194, n = 3 )  (Fig I) In the presence of 30 ILM 
THA the mean Ka was 117 nM (S D --- 57 13, n = 3) and m e a n  Bma x was 748 fmol/mg 
protein (S D = 195, n = 3) (Fig 1), indicative of competitive inhibition Double-reci- 
procal plots confirmed competitive inhibition with a mean K, of 15/IM (S D = 6 62, 
n = 3) At a concentration of 300/tM, THA had no effect on N M D A  receptor binding 
in a sensitive autoradlographic assay (data not shown) Preliminary experiments in&- 
cate that THA also displaces the PCP hgand MK-801 
Davenport et al have examined the effects of  THA and related compounds on 
N M D A  mediated neurotoxlclty and neuroexcltatlon [7] They found that THA was 
a moderately effective antagonist of NMDA,  that chohnesterase lnhlbltors were 
weak antagonists, and that the potassmm channel blocker 4-amlnopyrldlne had no 
N M D A  antagonist properties This rank order of potency accords well with our 
binding data 
Drugs active at the PCP receptor are thought to block N M D A  responses noncom- 
petltlvely through actions at the cation channel associated with the N M D A  receptor 
[5] THA is a known potassium and sodium channel blocker and the closely related 
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Fig 1 Scatchard plot demonstrating competitive mhlblhon (representative plot from one ol 3 experi- 
ments) 
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d u r a t i o n  o f  anes thesm and  emergence  s y m p t o m s  assocmted  w~th d~ssocmtlve anes-  
theslcs Thts suggests that  T H A  antagontzes  the effects o f  dlssoclat tve anesthet tcs  
These da ta ,  toge ther  wtth those o f  D a v e n p o r t  et a l ,  suggest  tha t  T H A  may  have 
mixed  a g o m s t - a n t a g o m s t  p roper t i e s  a t  the PCP  recep tor  N o  PCP a n t a g o m s t  has yet 
been found  and  such an  agent  cou ld  be o f  grea t  mteres t  
The  a n t a g o m s m  o f  T H A  for N M D A  could  l tmlt  the effectiveness o f  T H A  m D A T  
Decreases  in P C P / N M D A  receptors  in D A T  are pa r t i cu la r ly  p rominen t  tn the h tppo-  
campus  In a d d m o n  to being a focus o f  p a t h o l o g y  in D A T ,  it is known  tha t  the m a j o r  
afferent p ro jec t ion  to the  h lppocampus ,  the pe r fo r an t  pa thway ,  is seriously affected 
m D A T  [9] This  pa thway  is felt to be g lu tamate rg lc  and  deficiencies m g lu t ama te  
neu ro t r ansmls s lon  m a y  con t r tbu te  to the m e m o r y  def io t s  o f  D A T  F u r t h e r  decreases 
m N M D A  medmted  neuro t ransmlss lon  m the h l p p o c a m p u s  could  exacerba te  the 
m e m o r y  deficits o f  D A T  On the o ther  hand ,  should  T H A  prove  to have PCP an tago-  
nist  p roper t i e s  tt cou ld  po ten t t a te  N M D A  receptor  neuro t ransmlss ton  Even a 
modes t  increase m the eff ioency o f  g lu tamate rg tc  neuro t ransmlss lon  m the h tppo-  
campus  could  be o f  benefit  m D A T  
Fmal ly ,  it should  be po in ted  ou t  tha t  the / ( I  o f  T H A  for T C P  b m d m g  is cons idera-  
bly  higher  than  the r epor ted  effecttve serum concen t ra t ion  o f  T H A  The effecttve 
b r am concen t ra t ton  is unknown  and  a p r o p e r  assessment  o f  the relevance o f  our  find- 
rags awai ts  d e t e r m m a t t o n  o f  this value 
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